SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

Polyrizon (PLRZ) is trending due to positive news regarding its nasal spray manufacturing milestone and superior mucoadhesion results, sparking significant after-hours momentum. The community is actively discussing its potential as a multi-day runner and comparing it to other low-float Israeli stocks that have recently experienced substantial gains. Some traders, however, express concern about a potential dilution pump.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

TIGR is trending due to its recent earnings report, which showed record revenue and profit, sparking discussions about its undervaluation relative to competitors like HOOD. The community is highlighting the company's strong growth in global client assets and its potential for significant price appreciation, drawing comparisons to HOOD's earlier run-up.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors anticipate upcoming earnings, with community chatter focused on whether the company can sustain growth and profitability amid the increasing adoption of AI and automation; some are pointing to partnerships with major tech players as a positive sign, while others remain skeptical about its valuation and ability to maintain gains post-earnings.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending amid speculation and excitement around the robotics sector, driven by potential government support and company-specific developments like overnight trading highs and high trading volumes. Community members are actively discussing potential short squeezes and comparing SERV to other robotics plays, anticipating further gains and focusing on the company's growth prospects with its DoorDash partnership. Some see a buying opportunity, while others are wary, pointing to past volatility and dilution.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as the quantum computing sector garners attention, with discussions focusing on its superconducting QPU systems and potential for scalability compared to other quantum computing approaches. Community members debate the company's valuation relative to its revenue and the competitive landscape, while also discussing potential catalysts and trading strategies involving options. Some are optimistic about Rigetti's technology and long-term potential, while others express skepticism, citing concerns about profitability and competition from larger companies.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending due to concerns about AI sales performance after a report surfaced about lowered targets, which the company disputes, leading to market volatility. The community is actively discussing the validity of the report and its impact on MSFT's valuation compared to peers, with some seeing a buying opportunity amidst the uncertainty. Broader market sentiment and potential acquisitions remain key discussion points.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Recent reports suggest Netflix is vying for Warner Bros. Discovery assets, sparking community discussion around potential synergies and regulatory hurdles. The community is weighing the implications of Netflix potentially acquiring the studio and streaming service, including debates on content libraries and market dominance. Amidst these acquisition talks, there are also discussions on the stock's recent performance and future price movement, with some traders expressing bearish sentiments.

IMX is the native token for the Immutable X network, the first zk-rollup for NFT on Ethereum.

Immutable X

Immutable X is trending as community members discuss its bullish structure and potential for near-term gains, citing spot-driven volume and relative strength against Bitcoin. A new gaming hub launch on Polygon with quests and rewards also appears to be a factor, alongside discussion of staking rewards. Some traders are noting overbought conditions and upcoming token releases as potential risks.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki Token is trending as the community discusses its potential for growth, highlighting its development efforts compared to other meme coins. Ongoing conversations revolve around its market position relative to other tokens and anticipation for upcoming announcements. Some community members express excitement, while others discuss technical analysis and potential price movements.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

$PAW is gaining attention as it focuses on building enterprise-level infrastructure, including unified liquidity and compliance tools, which the community believes sets it apart from hype-driven coins. Discussions highlight its potential to bridge Web2 and Web3, attracting both retail and institutional interest. The upcoming Q1 2026 network return and refreshed identity are also key talking points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Third Harmonic Bio, Inc. (THRD) drew investor attention on Monday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.thirdharmonicbio.com/news-releases/news-release-details/third-harmonic-bio-announces-plan-liquidation-and-dissolution">announced </a>that its board of directors has approved a plan for the liquidation and dissolution of the firm and the distribution of remaining cash to stockholders.The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at their annual meeting on June 5.The company will subsequently delist its shares of common stock from Nasdaq.Third Harmonic Bio CEO said that after reviewing strategic alternatives, the management team and board of directors determined that returning cash to shareholders and selling its assets is the “best path forward.”The company expects that its existing capital resources, coupled with the anticipated net proceeds from the sale of certain clinical assets, will enable it to meet its remaining liabilities and obligations with sufficient reserves.The company estimates that the initial distribution will be between approximately $246.6 million and $255.4 million, or approximately $5.13 and $5.33 per share of common stock. The amount will be distributed after the company files for dissolution in the third quarter.It added that the estimates do not include any cash that may become available for distribution following sales of the company’s assets.The company said that it will complete all Phase 2 readiness activities for its lead product candidate THB335, aimed at treating chronic spontaneous urticaria, by mid-year to maximize the program's value, which will be sold as part of the dissolution plan.Following the announcement, shares of the company rocketed over 39% in Monday’s pre-market session.On Stocktwits, retail sentiment around Third Harmonic Bio fell from ‘neutral’ to ‘extremely bearish’ over the past 24 hours while message volume rose from ‘extremely low’ to ‘extremely high.’<figure class="image"><img style="aspect-ratio:650/149;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_14_at_7_59_17_AM_png_4ae3a9f87c.webp" alt="THRD's Sentiment Meter and Message Volume as of 8:05 a.m. ET on April 14, 2025 | Source: Stocktwits" width="650" height="149"><figcaption>THRD's Sentiment Meter and Message Volume as of 8:05 a.m. ET on April 14, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/THRD">THRD stock</a> fell by about 67% year-to-date and by 69% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/pfizer-ends-development-of-weight-loss-pill-danuglipron/chfCPelRba2">Pfizer Ends Development Of Weight Loss Pill Due To Potential Drug-Induced Liver Injury In A Patient</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered

The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual meeting of stockholders on June 5.

Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 38% Pre-Market, But Retail’s Shattered

Equity

The volume for Third Harmonic Bio stock increased for one day, resulting in a record-breaking daily growth of 204% of the 65-Day Volume Moving Average

THRD's total volume now sits at 229.4K. The +-0.21% price change was insignificant, leaving IBM's price at $9.44...

Third Harmonic Bio Welcomes New Director, Geoff McDonough

Third Harmonic Bio, Inc. (THRD) has issued an update. Geoff McDonough has been appointed as a Class III director at Third Harmonic Bio, Inc., follo...

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases...

Third Harmonic Bio Inc (THRD) Reports Decreased Net Loss in Q4, Aligns with Analyst Projections

THRD's Fiscal Discipline Leads to Lower Annual Net Loss Despite Zero RevenueRelated Stocks: THRD...

Third Harmonic Bio GAAP EPS of -$2.45 misses by $1.20

Third Harmonic Bio GAAP EPS of -$2.45 misses by $1.20...

Buy Rating for Third Harmonic Bio Amidst Promising Drug Pipeline and Market Potential

LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on THRD stock, giving a Buy rating today. Sam Slutsky has given his Buy rat...

TD Cowen Remains a Buy on Third Harmonic Bio, Inc. (THRD)

In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Third Harmonic Bio, Inc. (THRD Research Report). The company's...

Recap: Third Harmonic Bio Q4 Earnings

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

U.S. IND filed for THB335 with anticipated clinical trial start during 2Q'24 Strong financial position with cash and cash equivalents totaling $269.1 million as of December 31, 2023 SAN...

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.

THRD
THIRD HARMONIC BIO INC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest THRD News

THRDTHIRD HARMONIC BIO INC